Objective Cervical cancer screening is very important in the prevention and treatment of
cervical cancer. In China, the cervical screening strategy needs to be improved. To explore a …

Background The paradigm shift from cytological screening to Human Papillomavirus (HPV)-
based screening for cervical cancer allows the introduction of new technologies in sample …

Overexpression of HPV‐oncoproteins E6 and E7 is necessary for HPV‐driven cervical
carcinogenesis. Hence, these oncoproteins are promising disease‐specific biomarkers. We …

HPV‐16 and− 18 account for about 80% of cervical cancers. We evaluated the performance
of HPV‐16/18 oncoprotein to predict precancer and cancer in corresponding tissue biopsy …

Background It has been reported that high HPV DNA load and elevated E6 protein
expression correlate with cervical cancer, but no epidemiological study has been performed …

High‐risk human papillomavirus type 16/18 (HPV16/18) genotyping is unable to accurately
discriminate nonprogressive infections from those that will progress to cervical cancer. Our …

Background Cervical cancer is the second-most common gynecological cancer, early
screening plays a key role in the diagnosis and treatment of cervical intraepithelial …

Purpose A high-risk human papillomavirus E6/E7 mRNA (HR-HPV mRNA) assay is widely
used in cervical cancer screening in China. However, it is still unclear whether stand-alone …

摘要目的: 探讨预测高危型人乳头瘤病毒(high risk human papillomavirus, hrHPV)
阳性和宫颈上皮内瘤样病变1 级(cervical in⁃ traepithelial neoplasia grade 1, CIN1) …

Factors that differentiate risk of cervical cancer associated with infection with single versus
multiple HPV types are yet undefined. We hypothesize that E6 oncoprotein is one …